Extracellular vesicles versus lipid nanoparticles for the delivery of nucleic acids
Advanced Drug Delivery Reviews · 2024-12 · 215 · 115461
DOI: 10.1016/j.addr.2024.115461 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2024-12. Verfasst von Johannes Bader und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, 8093 Zurich, Switzerland. Hauptthemen laut MEDLINE: Extracellular Vesicles, Nanoparticles, Nucleic Acids, Lipids. Die Arbeit wurde bisher 113-mal zitiert (Crossref) und nennt 404 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ETH Zürich.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, 8093 Zurich, Switzerland.
- Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, 8093 Zurich, Switzerland. Electronic address: jleroux@ethz.ch.
Förderung
- ETH Zürich
Zitieren
APA
Bader, J., Brigger, F., & Leroux, J. C. (2024). Extracellular vesicles versus lipid nanoparticles for the delivery of nucleic acids. Advanced Drug Delivery Reviews, 215, 115461. https://doi.org/10.1016/j.addr.2024.115461
Vancouver
Bader J, Brigger F, Leroux JC. Extracellular vesicles versus lipid nanoparticles for the delivery of nucleic acids. Advanced Drug Delivery Reviews. 2024;215:115461. doi:10.1016/j.addr.2024.115461
BibTeX
@article{Bader2024,
author = {Bader, Johannes and Brigger, Finn and Leroux, Jean-Christophe},
title = {Extracellular vesicles versus lipid nanoparticles for the delivery of nucleic acids},
journal = {Advanced Drug Delivery Reviews},
year = {2024},
volume = {215},
pages = {115461},
doi = {10.1016/j.addr.2024.115461}
}
EUVIMED